Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Clearmind Medicine Inc increased its cash reserves by 4,114.74%, or 5.30m. Cash Flow from Financing totalled 11.66m or -- of revenues. In addition the company used 6.30m for operations while cash used for investing totalled 26.23k.
Cash flow per share | -3.86 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.8728 |
---|---|
Tangible book value per share | 0.8448 |
More ▼
Balance sheet in USDView more
Current ratio | 1.71 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0175 |
---|---|
Total debt/total capital | 0.0172 |
More ▼